Literature DB >> 8797662

Dystrophic neurite formation associated with age-related beta amyloid deposition in the neocortex: clues to the genesis of neurofibrillary pathology.

J C Vickers1, D Chin, A M Edwards, V Sampson, C Harper, J Morrison.   

Abstract

The formation of dystrophic neurites associated with beta amyloid plaques in Alzheimer's disease (AD) appears to involve a transformation of normal neuronal cytoskeletal proteins. In order to investigate what may be the earliest neuronal changes associated with the development of dystrophic neurites, we have examined the neurochemical profile of abnormal neuritic processes associated with the beta amyloid deposition in non-AD, aged cases. In all non-AD individuals demonstrating some degree of beta amyloid deposition in the superior frontal gyrus, clustered swollen and ring-like structures, located principally in layers II and III, were labeled with antibodies to phosphorylated and nonphosphorylated domains of the middle and high molecular weight neurofilament subunits. These abnormal neurites were not immunolabeled for tau or ubiquitin or stained with thioflavine S. Double labeling for neurofilaments and thioflavine S confirmed that these clusters of dystrophic neurites were associated with plaque-like deposits. These results show that anatomically and neurochemically specific forms of dystrophic neurites can occur in non-AD cases that contain beta amyloid deposition. If these abnormal neurites correspond to an immature form of the dystrophic neurites found in the neuritic plaques of Alzheimer's disease, then neurofibrillary pathology associated with this disease may begin with an initial misprocessing and accumulation of neurofilament proteins. Furthermore, these data are consistent with the proposal that the development of neurofibrillary pathology may begin with neurofilamentous hypertrophy in damaged distal processes followed by reactive changes in the cell bodies of origin of these fibers involving cytoskeletal alterations that ultimately lead to neurofibrillary tangle formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797662     DOI: 10.1006/exnr.1996.0133

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  19 in total

1.  Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ.

Authors:  Parvathi Rudrabhatla; Philip Grant; Howard Jaffe; Michael J Strong; Harish C Pant
Journal:  FASEB J       Date:  2010-07-12       Impact factor: 5.191

2.  C-terminal fragments of amyloid-beta peptide cause cholinergic axonal degeneration by a toxic effect rather than by physical injury in the nondemented human brain.

Authors:  Peter Kasa; Henrietta Papp; Janos Zombori; Peter Mayer; Frederic Checler
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 3.  Does beta-amyloid plaque formation cause structural injury to neuronal processes?

Authors:  Adele Woodhouse; Adrian K West; Jyoti A Chuckowree; James C Vickers; Tracey C Dickson
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 4.  Vaccination strategies for Alzheimer's disease: A new hope?

Authors:  Adele Woodhouse; Tracey C Dickson; James C Vickers
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

5.  Cuprizone-induced oligodendrocyte loss and demyelination impairs recording performance of chronically implanted neural interfaces.

Authors:  Steven M Wellman; Kelly Guzman; Kevin C Stieger; Lauren E Brink; Sadhana Sridhar; Mitchell T Dubaniewicz; Lehong Li; Franca Cambi; Takashi D Y Kozai
Journal:  Biomaterials       Date:  2020-02-06       Impact factor: 12.479

6.  Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities.

Authors:  Xiangyou Hu; Qi Shi; Xiangdong Zhou; Wanxia He; Hong Yi; Xinghua Yin; Marla Gearing; Allan Levey; Riqiang Yan
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

7.  The occurrence of aging-dependent reticulon 3 immunoreactive dystrophic neurites decreases cognitive function.

Authors:  Qi Shi; Xiangyou Hu; Marguerite Prior; Riqiang Yan
Journal:  J Neurosci       Date:  2009-04-22       Impact factor: 6.167

Review 8.  Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders.

Authors:  Aidong Yuan; Ralph A Nixon
Journal:  Brain Res Bull       Date:  2016-09-05       Impact factor: 4.077

Review 9.  A vaccine against Alzheimer's disease: developments to date.

Authors:  James C Vickers
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  Botulinum neurotoxin C initiates two different programs for neurite degeneration and neuronal apoptosis.

Authors:  Laura Berliocchi; Eugenio Fava; Marcel Leist; Volker Horvat; David Dinsdale; David Read; Pierluigi Nicotera
Journal:  J Cell Biol       Date:  2005-02-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.